Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 212-219

  Vanderah, Todd W ^a   Bernstein, Robert N ^a   Yamamura, Henry I ^a   Hruby, Victor J ^a   Porreca, Frank ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; ANTISERUM; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; MORPHINE; NALTRINDOLE; THIORPHAN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; DRUG INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN THRESHOLD; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MORPHINE; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, OPIOID, DELTA;

EID: 0030426728     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. BARRETT, R. W. AND VAUGHT, J. L.: The effects of receptor selective opioid peptides on morphine-induced analgesia. Eur. J. Pharmacol. 80: 427-430, 1982.
2. CHAILLET, P., MARCAIS-COLLADO, H., COSTENTIN, J., Yi, C-C., DE LA BAUME, S. AND SCHWARTZ, J-C.: Inhibition of enkephalin metabolism by, and antinociceptive activity of, Bestatin, an aminopeptidase inhibitor. Eur. J. Pharmacol. 86: 329-336, 1983.
3. COTTON, R., GILES, M. G., MILLER, L., SHAW, J. S. AND TIMMS, D.: ICI 174,864: A highly selective antagonist for the opioid δ-receptor. Eur. J. Pharmcol. 97: 331-332, 1984.
4. DOURISH, C. T., O'NEILL, M. F., COUGHLAN, J., KITCHENER, S. J. AND IVERSEN, S. D.: The selective CCK-B receptor antagonist L365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176: 35-44, 1990.
5. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. AND KREIL, G.: Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. Natl. Acad. Sci. U.S.A. 86:5188-5192, 1989.
6. HAMBROOK, J. M., MORGAN, B. A., RANCE, M. J. AND SMITH, C. F. C.: Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature (Lond.) 262: 782-783, 1976.
7. HEYMAN, J. S., MULVANEY, S. A., MOSBERG, H. I. AND PORRECA, F.: Evidence for μ-δ interactions in vivo. Soc. Neuroaci. 12: 1014, 1986.
8. HEYMAN, J. S., MULVANDY, S. A., MOSBERG, H. I. AND PORRECA, F.: Opioid δ receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420: 100-108, 1987.
9. 5]enkephalin. Eur. J. Pharmacol. 165: 1-10, 1989a.
10. HEYMAN, J. S., JIANO, Q., ROTHMAN, R. B., MOSBERG, H. I. AND PORRECA, F.: Modulation of μ-mediated antinociception by δ agonists: Characterization with antagonists. Eur. J. Pharmacol. 169: 43-52, 1989b.
11. HILL, D. R. AND WOODRUFF, G. N.: Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L365,260. Brain Res. 526: 276-283, 1990.
12. HUGHES, J., BODEN, P., COSTALL, B., DOMENEY, A., KELLY, E., HORWELL, D. C., HUNTER, J. C., PINNOCK, R. D. AND WOODRUFF, G. N.: Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U.S.A. 87: 6728-6732, 1990.
13. HYLDEN, J. L. K. AND WILCOX, G. W.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
14. ITOH, S., KATSUURA, G. AND MAEDA, Y.: Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat. Eur. J. Pharmacol. 80: 421-425, 1982.
15. JAMES, I. F. AND GOLDSTEIN, A.: Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol. Pharmacol. 25: 337-342, 1984.
16. non-complexed site. J. Pharmacol. Exp. Ther. 255: 636-641, 1990a.
17. 2]deltorphin II, a highly selective δ agonist in vivo. Life Sci. Pharmacol. Lett. 47: PL-43-PL-47, 1990b.
18. JIANG, Q., MOSBERG, H. I. AND PORHECA, F.: Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. J. Pharmacol. Exp. Ther. 254: 683-689, 1990c.
19. LAVIGNE, G. J., MILLINGTON, W. R. AND MUELLER, G. P.: The CCK-A and CCK-B receptor antagonists, devazepide and L365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment. Neuropeptides 21: 119-129, 1992.
20. LEE, N. M., LEYBIN, L., CHANG, J. K. AND LOH, H. H.: Opiate and peptide interaction: Effect of enkephalins on morphine analgesia. Eur. J. Pharmacol. 68: 181-185, 1980.
21. LORD, J. A. H., WATERFIELD, A. A., HUGHES, J. AND KOSTERLITZ, H. W.: Endogenous opioid peptides: Multiple agonists and receptors. Nature (Lond.) 267: 495-499, 1977.
22. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258: 583-587, 1991.
23. MOSBERG, H. I., HURST, R., HRUBY, V. J., GEE, K., YAMAMURA, H. I., GALLIGAN, J. J. AND BURKS, T. F.: Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. Natl. Acad. Sci. U.S.A. 80: 5871-5874, 1983.
24. NICHOLS, M. L., BIAN, D., OSSIPOV, M. H., LAI, J. AND PORRECA, F.: Regulation of opioid antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J. Pharmacol. Exp. Ther. 275: 1339-1345, 1995.
25. B antagonist in the rat. Neurosci. Lett. 181: 9-12, 1994.
26. PORRECA, F. AND BURKS, T. F.: The spinal cord as a site of opioid gastrointestinal effects in mice. J. Pharmacol. Exp. Ther. 227: 22-27, 1983.
27. PORRECA, F., MOSBERG, H. I., HURST, R., HRUBY, V. J. AND BURKS, T. F.: Roles of μ, δ and κ opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J. Pharmacol. Exp. Ther. 230: 341-348, 1984.
28. PORTOGHESE, P. S., SULTANA, M. AND TAKEMORI, A. E.: Naltrindole 5′-isothiocyanate: A nonequilibrium, highly selective δ opioid receptor antagonist. J. Med. Chem. 33: 1547-1548, 1990.
29. STANFA, L. C. AND DICKENSON, A. H.: Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenan inflammation. Br. J. Pharmacol. 108: 967-973, 1993.
30. STANFA, L. C., DICKENSON, A. H., Xu, X.-J. AND WIESENFELD-HALLIN, Z.: Cholecystokinin and morphine analgesia: Variations on a theme. Trends in Pharmacol. Sci. 15: 65-66, 1994.
31. 5]enkephalin antiserum-sensitive enhancement of morphine antinociception. NeuroReport 5: 2601-2605, 1994.
32. VANDERAH, T. W., WILD, K. D., TAKEMORI, A. E., SULTANA, M., PORTOGHESE, P. S., BOWEN, W. D., HRUBY, V. J., MOSBERG, H. I. AND PORRECA, F.: Modulation of morphine antinociception by swim-stress in the mouse: Involvement of supraspinal opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 267: 449-455, 1993.
33. VAUGHT, J. L. AND TAKEMORI, A. E.: Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208: 86-90, 1979.
34. VAUGHT, J. L., ROTHMAN, R. B. AND WESTFALL, T. C.: Mu and delta receptors: Their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30: 1443-1455, 1982.
35. WATKINS, L. R., KINSCHEK, I. B. AND MAYER, D. J.: Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Brain Res. 327: 169-180, 1985.
36. WEISENFELD-HALLIN, Z. AND DURANTI, R.: Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexor reflex in the rat. Peptides 8: 153-158, 1987.
37. WEISENFELD-HALLIN, Z., Xu, X-J., HUGHES, J., HORWELL, D. C. AND HOKFELT, T.: PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc. Natl. Acad. Sci. 87: 7105-7109, 1990.
38. WOOLF, C. J. AND DOUBELL, T. P.: The pathophysiology of chronic pain-increased sensitivity to low threshold Aβ-fibre inputs. Curr. Opin. Neurobio. 4: 525-534, 1994.